Tetrahydropapaveroline acts as a beta-sympathomimetic agent with positive inotropic, chronotropic, and vasodilatory effects in preclinical models.
No immediate clinical implications from animal data; hypothesis-generating for beta-agonist effects and requires human validation.
Tetrahydropapaveroline (thp) exerts β-sympathomimetic effects similar to those of isoprenaline. On guinea-pig isolated atria, thp elicits positive inotropic and chronotropic activities which are not abolished by previous reserpinization of the animals; on isolated mammalian heart these effects are associated with an increase in coronary flow. In the dog, thp increases myocardial contractile force and rate, elicits a hypotensive effect and stimulates respiratory activity in normal and reserpinized animals; when injected intra-arterially the drug causes vasodilatation. All the effects are prevented by the β-adrenergic blocking agents propranolol, dichloroisoprenaline and pronethalol. Structure-activity relationships between tetrahydroisoquinoline derivatives and their open-ring phenylethylamine congeners, which are closely related to sympathomimetic drugs, are discussed.
No takes yet. Share an insight, caveat, or question.
Santi et al. (1967) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: